Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Magn Reson Imaging. 2020 Jul 2;72:87–94. doi: 10.1016/j.mri.2020.06.017

Table 1.

Indications for screening BMRI (N=73)

Indication Number (%)
BRCA1
 Pathologic variant 2 (2.7)
 VUS 3 (4.1)
BRCA2
 Pathologic variant 9 (12.3)
 VUS 2 (2.7)
Other gene mutation
 CDH1 1 (1.3)
 PALB2 1 (1.3)
 PALB2 VUS 1 (1.3)
Chest radiation therapy before age 30 2 (2.7)
Risk model with LTR calculation ≥20%
 Gail 22 (30.1)
 Tyrer-Cuzick 18 (24.7)
 Claus 12 (16.4)

BMRI: breast magnetic resonance imaging; VUS: variant of uncertain significance; LTR: lifetime risk.